Semaglutide, when used as a subcutaneous injection, has a half-life of 5-6 days
We provide holistic care, considering drug interactions, insurance acceptance , and overall health, ensuring a well-rounded approach to your well-being
What to know Most side effects appear early in treatment and usually improve as your body adjusts to the dose
It is important to understand that retatrutide is not currently approved for use in the United Kingdom by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA)
Last reviewed: May 14, 2026 Last updated: May 14, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The program costs $149 per month and is available to individuals with a BMI of 21 or higher